- Home
- FRSH vs GRFS Comparison
FRSH vs GRFS Comparison
Compare FRSH & GRFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FRSH
- GRFS
- Stock Information
- Founded
- FRSH 2010
- GRFS 1940
- Country
- FRSH United States
- GRFS Spain
- Employees
- FRSH N/A
- GRFS N/A
- Industry
- FRSH EDP Services
- GRFS Biotechnology: Pharmaceutical Preparations
- Sector
- FRSH Technology
- GRFS Health Care
- Exchange
- FRSH Nasdaq
- GRFS Nasdaq
- Market Cap
- FRSH N/A
- GRFS 5.1B
- IPO Year
- FRSH 2021
- GRFS 2006
- Fundamental
- Price
- FRSH $14.11
- GRFS $7.11
- Analyst Decision
- FRSH Buy
- GRFS
- Analyst Count
- FRSH 13
- GRFS 0
- Target Price
- FRSH $20.62
- GRFS N/A
- AVG Volume (30 Days)
- FRSH 2.7M
- GRFS 1.1M
- Earning Date
- FRSH 04-30-2025
- GRFS 01-01-0001
- Dividend Yield
- FRSH N/A
- GRFS N/A
- EPS Growth
- FRSH N/A
- GRFS 283.33
- EPS
- FRSH N/A
- GRFS 0.24
- Revenue
- FRSH $720,420,000.00
- GRFS $7,467,006,939.00
- Revenue This Year
- FRSH $15.45
- GRFS $8.45
- Revenue Next Year
- FRSH $13.26
- GRFS $7.08
- P/E Ratio
- FRSH N/A
- GRFS $34.17
- Revenue Growth
- FRSH 20.79
- GRFS 9.41
- 52 Week Low
- FRSH $10.81
- GRFS $5.79
- 52 Week High
- FRSH $19.77
- GRFS $9.96
- Technical
- Relative Strength Index (RSI)
- FRSH 33.78
- GRFS 34.78
- Support Level
- FRSH $15.02
- GRFS $7.13
- Resistance Level
- FRSH $16.48
- GRFS $7.81
- Average True Range (ATR)
- FRSH 0.54
- GRFS 0.23
- MACD
- FRSH -0.03
- GRFS -0.12
- Stochastic Oscillator
- FRSH 12.55
- GRFS 10.08
About GRFS Grifols S.A.
As a vertically integrated plasma derivative producer, Spain-based Grifols collects plasma and then manufactures and sells plasma-derived products globally. By acquiring Talecris in 2011, Grifols dramatically expanded its plasma-derived product portfolio, and following the firm's Biotest acquisition in April 2022, the biopharma business contributed 84% of sales in 2023. Grifols also has smaller segments including diagnostics (10% of sales) and biosupplies.